Fisher & Paykel Healthcare saw the highest growth of 1.43% in patent filings in May and 0.94% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.93% and grants by 0.94%. GlobalData’s DataBook provides a comprehensive analysis of Fisher & Paykel Healthcare’s patent filings and grants. Buy the databook here.
Fisher & Paykel Healthcare has been focused on protecting inventions in European Patent Office(EPO) with 75 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 19% filings and 22% grants. The United States(US), European Patent Office(EPO), Australia(AU), and China(CN) patent Office are among the top ten patent offices where Fisher & Paykel Healthcare is filings its patents. Among the top granted patent authorities, Fisher & Paykel Healthcare has 23% of its grants in United States(US), 22% in European Patent Office(EPO) and 17% in Australia(AU).
ResMed could be the strongest competitor for Fisher & Paykel Healthcare
Patents related to healthtech and industrial automation lead Fisher & Paykel Healthcare's portfolio
Fisher & Paykel Healthcare has the highest number of patents in healthtech followed by, industrial automation and remote patient monitoring. For healthtech, nearly 26% of patents were filed and 29% of patents were granted in Q2 2024.
Anesthesia and respiratory devices related patents lead Fisher & Paykel Healthcare portfolio followed by other remote patient monitoring, and nasal cannula
Fisher & Paykel Healthcare has highest number of patents in anesthesia and respiratory devices followed by other remote patient monitoring, nasal cannula, healthcare it, and electronic document mgmt. For anesthesia and respiratory devices, nearly 52% of patents were filed and 62% of patents were granted in Q2 2024.
For comprehensive analysis of Fisher & Paykel Healthcare's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.